Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-400
Closed -$20.3K 155
2026
Q1
$20.3K Hold
400
0.01% 146
2025
Q4
$11.8K Hold
400
0.01% 141
2025
Q3
$10.3K Hold
400
0.01% 142
2025
Q2
$11K Hold
400
0.01% 145
2025
Q1
$11.3K Hold
400
0.01% 144
2024
Q4
$16.6K Hold
400
0.01% 143
2024
Q3
$26.7K Hold
400
0.02% 124
2024
Q2
$47.5K Hold
400
0.03% 121
2024
Q1
$42.6K Hold
400
0.03% 120
2023
Q4
$39.8K Hold
400
0.03% 118
2023
Q3
$39.8K Hold
400
0.03% 118
2023
Q2
$48.6K Sell
400
-100
-20% -$13.3K 0.04% 130
2023
Q1
$76.8K Buy
+500
New +$82.5K 0.08% 125

Other funds holding MRNA

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s MRNA Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Moderna (MRNA) in Q2 2026, closing a stake of 400 shares — an estimated $20.3K sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in MRNA in Q1 2023 and held it in 13 quarters. The position peaked at $76.8K in Q1 2023. 551 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 400 Moderna shares in Q2 2026, an estimated $20.3K.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Moderna in Q1 2023 and held it in 13 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Moderna position peaked at $76.8K in Q1 2023.
  • 551 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.